Knight Therapeutics (KHTRF) Short Interest Ratio & Short Volume $4.39 0.00 (0.00%) As of 04/4/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Knight Therapeutics Short Interest DataKnight Therapeutics (KHTRF) has a short interest of 439,100 shares. This marks a -11.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 141.6, indicating that it would take 141.6 days of the average trading volume of 1,903 shares to cover all short positions.Current Short Interest439,100 sharesPrevious Short Interest493,500 sharesChange Vs. Previous Month-11.02%Dollar Volume Sold Short$1.83 millionShort Interest Ratio141.6 Days to CoverLast Record DateMarch 15, 2025Today's Trading Volume1,300 sharesAverage Trading Volume1,903 sharesToday's Volume Vs. Average68% Short Selling Knight Therapeutics? Sign up to receive the latest short interest report for Knight Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKHTRF Short Interest Over TimeKHTRF Days to Cover Over TimeKHTRF Percentage of Float Shorted Over Time Remove Ads Knight Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025439,100 shares $1.83 million -11.0%N/A141.6 $4.17 2/28/2025493,500 shares $1.89 million -1.3%N/A329 $3.83 2/15/2025500,000 shares $1.99 million +5.8%N/A416.7 $3.98 1/31/2025472,500 shares $1.87 million +14.4%N/A337.5 $3.96 1/15/2025413,200 shares $1.53 million +9.7%N/A129.1 $3.70 12/31/2024376,600 shares $1.36 million +7.2%N/A198.2 $3.61 12/15/2024351,200 shares $1.31 million +3.0%N/A125.4 $3.73 11/30/2024341,000 shares $1.28 million -39.1%N/A7.3 $3.75 11/15/2024560,000 shares $2.06 million +62.2%N/A37.6 $3.69 10/31/2024345,200 shares $1.39 million +34.8%N/A119 $4.04 Get the Latest News and Ratings for KHTRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/2024256,100 shares $1.07 million +17.4%N/A128.1 $4.19 9/30/2024218,100 shares $950,916.00 -0.2%N/A94.8 $4.36 9/15/2024218,600 shares $966,212.00 +5.5%N/A128.6 $4.42 8/31/2024207,300 shares $852,003.00 +1.3%N/A76.8 $4.11 8/15/2024204,600 shares $840,906.00 -2.7%N/A55.3 $4.11 7/31/2024210,300 shares $868,539.00 -0.8%N/A70.1 $4.13 7/15/2024211,900 shares $885,742.00 -0.4%N/A40 $4.18 6/30/2024212,700 shares $882,705.00 -2.0%N/A44.3 $4.15 6/15/2024217,000 shares $902,720.00 -3.6%N/A433.9 $4.16 5/31/2024225,000 shares $983,475.00 +4.8%N/A59.2 $4.37 5/15/2024214,700 shares $942,533.00 -3.0%N/A55.1 $4.39 4/30/2024221,400 shares $927,666.00 +2.0%N/A82 $4.19 4/15/2024217,000 shares $909,230.00 +3.8%N/A47.2 $4.19 3/31/2024209,100 shares $819,672.00 -0.1%N/A7.1 $3.92 3/15/2024209,300 shares $830,921.00 -10.4%N/A33.8 $3.97 2/29/2024233,600 shares $955,424.00 -8.1%N/A21 $4.09 2/15/2024254,300 shares $1.04 million -0.9%N/A68.7 $4.11 1/15/2024230,500 shares $965,564.50 -2.9%N/A74.3 $4.19 12/31/2023237,300 shares $939,708.00 -2.4%N/A92.4 $3.96 12/15/2023243,100 shares $940,553.90 -45.2%N/A47.7 $3.87 11/30/2023443,500 shares $1.72 million -7.7%N/A119.9 $3.88 11/15/2023480,300 shares $1.81 million -19.4%N/A64.9 $3.76 10/31/2023596,000 shares $1.94 million +103.6%N/A220.7 $3.26 10/15/2023292,800 shares $983,808.00 +11.2%N/A6.6 $3.36 9/30/2023263,400 shares $874,539.10 -32.5%N/A39.3 $3.32 9/15/2023390,400 shares $1.28 million +6.7%N/A61 $3.29 8/31/2023366,000 shares $1.25 million +16.0%N/A8715.1 $3.41 8/15/2023315,600 shares $1.04 million -8.8%N/A3156 $3.31 7/31/2023345,900 shares $1.27 million +19.7%N/A150.4 $3.66 7/15/2023289,100 shares $1.09 million -3.2%N/A321.2 $3.78Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 6/30/2023298,600 shares $1.08 million +42.3%N/A64.9 $3.62 6/15/2023209,900 shares $761,937.00 -51.7%N/A8.2 $3.63 5/31/2023434,300 shares $1.58 million -29.6%N/A24.3 $3.63 5/15/2023616,700 shares $2.22 million +31.1%N/A1541.8 $3.60 4/30/2023470,400 shares $1.63 million +93.2%N/A470.4 $3.46 4/15/2023243,500 shares $881,470.00 +42.6%N/A19.5 $3.62 3/31/2023170,800 shares $561,078.00 +77.4%N/A27.5 $3.29 3/15/202396,300 shares $351,495.00 -22.0%N/A53.5 $3.65 2/28/2023123,500 shares $463,495.50 -5.6%N/A19.6 $3.75 2/15/2023130,800 shares $510,460.08 -65.2%N/A1308 $3.90 1/31/2023375,700 shares $1.47 million -16.8%N/A46.4 $3.90 1/15/2023451,300 shares $1.79 million -12.5%N/A161.2 $3.96 12/30/2022515,700 shares $1.96 million +26.0%N/A13.3 $3.80 12/15/2022409,400 shares $1.58 million +69.3%N/A4094 $3.86 11/30/2022241,800 shares $961,880.40 +103.7%N/A2418 $3.98 11/15/2022118,700 shares $472,188.60 -43.1%N/A1187 $3.98 10/31/2022208,500 shares $817,737.00 +37.4%N/A2085 $3.92 10/15/2022151,700 shares $579,038.90 +31.8%N/A758.5 $3.82 9/30/2022115,100 shares $452,688.30 +142.3%N/A115.1 $3.93 9/15/202247,500 shares $220,875.00 -4.6%N/A0 $4.65 8/31/202249,800 shares $231,570.00 +20.3%N/A124.5 $4.65 8/15/202241,400 shares $194,103.90 -42.4%N/A6.2 $4.69 7/31/202271,900 shares $319,955.00 -6.5%N/A359.5 $4.45 7/15/202276,900 shares $332,208.00 -23.8%N/A256.3 $4.32 6/30/2022100,900 shares $401,582.00 -22.2%N/A1009 $3.98 6/15/2022129,600 shares $528,768.00 -19.4%N/A117.8 $4.08 5/31/2022160,700 shares $691,010.00 +10.5%N/A47.3 $4.30 5/15/2022145,400 shares $588,870.00 -2.1%N/A80.8 $4.05 4/30/2022148,500 shares $622,660.50 +2.1%N/A148.5 $4.19 4/15/2022145,500 shares $611,100.00 -51.5%N/A363.8 $4.20 3/31/2022300,100 shares $1.23 million +59.6%N/A1500.5 $4.11 3/15/2022188,000 shares $802,760.00 -8.5%N/A626.7 $4.27 2/28/2022205,500 shares $871,320.00 -6.2%N/A40.3 $4.24 2/15/2022219,000 shares $941,700.00 -33.0%N/A64.4 $4.30 1/31/2022326,900 shares $1.43 million +41.8%N/A155.7 $4.36 1/15/2022230,600 shares $968,520.00 -15.1%N/A2306 $4.20 12/31/2021271,600 shares $1.13 million -5.9%N/A39.9 $4.16 12/15/2021288,500 shares $1.15 million +5.1%N/A72.1 $4.00 11/30/2021274,400 shares $1.12 million -24.0%N/A40.4 $4.10 11/15/2021360,900 shares $1.53 million -14.1%N/A11.2 $4.23 10/29/2021420,100 shares $1.75 million +53.3%N/A131.3 $4.15 10/15/2021274,000 shares $1.18 million -38.8%N/A47.2 $4.32 9/30/2021447,700 shares $1.93 million -7.1%N/A81.4 $4.31 9/15/2021482,000 shares $2.01 million -3.2%N/A150.6 $4.16 8/31/2021497,800 shares $2.11 million -17.6%N/A54.1 $4.25 8/13/2021604,400 shares $2.73 million -6.5%N/A167.9 $4.51 7/30/2021646,700 shares $2.65 million +39.1%N/A6.4 $4.09 7/15/2021464,900 shares $1.94 million +21.9%N/A101.1 $4.18 6/30/2021381,500 shares $1.64 million -34.2%N/A5.5 $4.30 6/15/2021580,000 shares $2.52 million -16.3%N/A1933.3 $4.34Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 5/28/2021726,100 shares $3.15 million -11.1%N/A907.6 $4.33 5/14/2021817,000 shares $3.52 million +4.4%N/A907.8 $4.31 4/30/2021782,400 shares $3.45 million -25.9%N/A23.9 $4.40 4/15/20211,056,300 shares $4.45 million -7.3%N/A8.1 $4.21 3/31/20211,139,900 shares $4.92 million -19.0%N/A11.5 $4.31 3/15/20211,408,000 shares $5.95 million -26.0%N/A327.4 $4.23 2/26/20211,902,200 shares $8.07 million -5.1%N/A3804.4 $4.24 2/12/20212,004,500 shares $8.90 million -29.7%N/A208.8 $4.44 1/29/20212,852,200 shares $12.06 million -37.9%N/A316.9 $4.23 1/15/20213,093,500 shares $12.86 million +6.6%N/A499 $4.16 12/31/20204,594,900 shares $19.30 million +48.5%N/A216.7 $4.20 12/15/20203,093,500 shares $12.69 million +6.6%N/A499 $4.10 11/30/20202,903,000 shares $11.84 million +5.1%N/A205.9 $4.08 11/15/20202,763,400 shares $11.41 million +0.1%N/A307 $4.13 10/30/20202,761,100 shares $11.84 million +11.1%N/A13805.5 $4.29 10/15/20202,485,600 shares $10.76 million -6.1%N/A994.2 $4.33 9/30/20202,647,100 shares $11.54 million +0.6%N/A472.7 $4.36 9/15/20202,630,300 shares $12.27 million +1.6%N/A417.5 $4.67 8/31/20202,590,200 shares $12.32 million -1.3%N/A221.4 $4.76 8/14/20202,625,200 shares $13.43 million +0.7%N/A276.3 $5.12 7/31/20202,606,000 shares $13.59 million -3.9%N/A2004.6 $5.22 7/15/20202,712,700 shares $13.92 million +3.3%N/A1043.3 $5.13 6/30/20202,626,200 shares $14.05 million -0.3%N/A937.9 $5.35 6/15/20202,634,400 shares $13.22 million -2.5%N/A13172 $5.02 5/29/20202,702,300 shares $14.79 million -1.0%N/A27023 $5.47 5/15/20202,728,100 shares $14.43 million +10.0%N/A13640.5 $5.29 4/30/20202,480,300 shares $13.84 million +2.0%N/A729.5 $5.58 4/15/20202,432,900 shares $11.99 million +3.1%N/A1158.5 $4.93 KHTRF Short Interest - Frequently Asked Questions What is Knight Therapeutics' current short interest? Short interest is the volume of Knight Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 439,100 shares of KHTRF short. Learn More on Knight Therapeutics' current short interest. What is a good short interest ratio for Knight Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KHTRF shares currently have a short interest ratio of 142.0. Learn More on Knight Therapeutics's short interest ratio. Is Knight Therapeutics' short interest increasing or decreasing? Knight Therapeutics saw a decline in short interest in March. As of March 15th, there was short interest totaling 439,100 shares, a decline of 11.0% from the previous total of 493,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), Strategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Knight Therapeutics stock? Short selling KHTRF is an investing strategy that aims to generate trading profit from Knight Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Knight Therapeutics? A short squeeze for Knight Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KHTRF, which in turn drives the price of the stock up even further. How often is Knight Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KHTRF, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies 1933 Industries Short Interest 4Cable TV International Short Interest 4Front Ventures Short Interest AB Science Short Interest Acreage Short Interest Acreage Short Interest Aleafia Health Short Interest Almirall Short Interest Alvotech Short Interest American Green Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:KHTRF) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KHTRF Stock Free KHTRF Stock Alerts